Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Registry Experience at the WAshington Hospital CenteR, DeS - Taxus Liberte vs Xience V

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01134159

Acronym

REWARDS TLX

Enrollment

1200

Registered

2010-05-31

Start date

2010-06-30

Completion date

2010-09-30

Last updated

2011-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients 18 years of age or older, both genders * Underwent PCI with Taxus Liberte (alone) or Xience (alone)

Exclusion criteria

* Underwent PCI with a non-Taxus Liberte or Xience V DES during the same procedure * Received both Taxus-Liberte and Xience-V during the same index procedure * Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel or prasugrel).

Design outcomes

Primary

Measure	Time frame	Description
Major adverse cardiac events,	1 year	A composite of all-cause death, Q-wave myocardial infarction, and target vessel revascularization

Secondary

Measure	Time frame
Stent thrombosis	1 year
Target vessel revascularization	1 year
Cardiac death	1 year

Countries

United States

Outcome results